Temoporfin‐mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: A multicenter study (Q42905060)

10 November 2017

title

Temoporfin-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: A multicenter study (English)

1 reference

https://api.crossref.org/works/10.1002/HED.21368

10 November 2017

Temoporfin‐mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: A multicenter study (English)

1 reference

15 July 2024

1 reference

1 reference

head and neck carcinoma

1 reference

Ing Bing Tan

1 reference

10 November 2017

Gilles Dolivet

1 reference

10 November 2017

Philippe Ceruse

1 reference

10 November 2017

Vincent Vander Poorten

1 reference

10 November 2017

Gerda Roest

1 reference

10 November 2017

Winrich Rauschning

1 reference

10 November 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20848401

15 July 2024

publication date

1 December 2010

1 reference

full work available at URL

10 November 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhed.21368

1 reference

https://api.crossref.org/works/10.1002/HED.21368

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hed.21368

15 July 2024

1 reference

https://api.crossref.org/works/10.1002/HED.21368

15 July 2024

1 reference

10 November 2017

1 reference

10 November 2017

1 reference

10 November 2017

page(s)

1597-1604

1 reference

Global cancer statistics, 2002

10 November 2017

cites work

1 reference

7 January 2021

Estimates of the cancer incidence and mortality in Europe in 2006.

1 reference

7 January 2021

Cancer statistics, 1994.

1 reference

7 January 2021

Growth rate of head and neck tumors

1 reference

7 January 2021

Prognostic factors for loco/regional control and metastasis and the impact on survival

1 reference

7 January 2021

A comparison of radiotherapy or radiochemotherapy with symptomatic treatment alone in patients with advanced head and neck carcinomas

1 reference

7 January 2021

Salvage treatment for recurrent squamous cell carcinoma of the oral cavity

1 reference

7 January 2021

Risk of multiple primary tumors following oral squamous-cell carcinoma

1 reference

7 January 2021

1 reference

7 January 2021

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study

1 reference

7 January 2021

IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.

1 reference

7 January 2021

Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone?

1 reference

7 January 2021

A review on re-irradiation for recurrent and second primary head and neck cancer

1 reference

7 January 2021

Chemotherapy- and radiotherapy-induced mucositis in head and neck cancer patients: new trends in pathophysiology, prevention and treatment

1 reference

7 January 2021

1 reference

7 January 2021

Clinical and preclinical photodynamic therapy

1 reference

7 January 2021

mTHPC-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study of 128 patients

1 reference

7 January 2021

The importance of in situ light dosimetry for photodynamic therapy of oral cavity tumors.

1 reference

7 January 2021

Design considerations for AIDS trials

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.21368

1 reference

10 November 2017

1 reference